semaglutide and alzheimer's Focus: After weight loss, may be next frontier for drugs like Ozempic Semaglutide in early-stage Alzheimer's Disease

It is unknown whether BYDUREON BCise causes thyroid C-cell tumors, including medullary thyroid carcinoma (MTC) in humans, as the human relevance of exenatide extended-release-induced rodent thyroid C-cell tumors has not been determined BYDUREON BCise is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

The trial provided table salt enriched with sodium selenite to the population of one township (20,847 people) using four other townships as controls

When patients stop taking semaglutide, their bodies begin adjusting to the absence of GLP-1 receptor stimulation

In addition to promoting weight loss, elecoglipron was associated with reductions in multiple exploratory cardiometabolic risk markers, including blood pressure, waist circumference, and high-sensitivity C-reactive protein